Evidence map›Paper›PMID 26883906›Full record

ReviewMolecules and cells2016

N-Terminal Acetylation-Targeted N-End Rule Proteolytic System: The Ac/N-End Rule Pathway.

Kang-Eun Lee, Ji-Eun Heo, Jeong-Mok Kim, Cheol-Sang Hwang

Abstract readReview
In one paragraph

Review in Molecules and cells, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Article
  3. An Enigma of N-termini dependent protein degradation.Biochemistry and biophysics reports · 2025
    Article
  4. Degrons: defining the rules of protein degradation.Nature reviews. Molecular cell biology · 2025
    Review
  5. Article
  6. Fine mapping and prediction of a candidate gene for wrinkled rind in melon (Cucumis melo L.).TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Frontiers in molecular biosciences · 2023
    Article
  11. Review
  12. CRL2Nature communications · 2022
    Article
  13. Label-Free Quantitative Proteomics Reveal the Involvement of PRT6 inInternational journal of molecular sciences · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. NAA10 as a New Prognostic Marker for Cancer Progression.International journal of molecular sciences · 2020
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kang-Eun LeeDepartment of Life Sciences, Pohang University of Science and Technology, Pohang, Gyeongbuk 790-784, Korea.
Ji-Eun HeoDepartment of Life Sciences, Pohang University of Science and Technology, Pohang, Gyeongbuk 790-784, Korea.
Jeong-Mok KimDepartment of Life Sciences, Pohang University of Science and Technology, Pohang, Gyeongbuk 790-784, Korea.
Cheol-Sang HwangDepartment of Life Sciences, Pohang University of Science and Technology, Pohang, Gyeongbuk 790-784, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although Nα-terminal acetylation (Nt-acetylation) is a pervasive protein modification in eukaryotes, its general functions in a majority of proteins are poorly understood. In 2010, it was discovered that Nt-acetylation creates a specific protein degradation signal that is targeted by a new class of the N-end rule proteolytic system, called the Ac/N-end rule pathway. Here, we review recent advances in our understanding of the mechanism and biological functions of the Ac/N-end rule pathway, and its crosstalk with the Arg/N-end rule pathway (the classical N-end rule pathway).

Indexed as

Protein Processing, Post-TranslationalAcetylationHumansProteinsProteolysisSignal TransductionProteinsdegronN-end ruleN-terminal acetylationproteolysisubiquitin

Identifiers

PMID26883906
PMCPMC4794598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.